Panelists will discuss considerations for resuming pre-pandemic level visits and procedures for patients with CLL, Acute , and Multiple Myeloma. Panelists will also discuss their wins and challenges with providing care to respective patients in a pandemic.

The speaker will discuss considerations around the COVID-19 vaccines and interpret the respective NCCN guidance for patients with CLL and other cancers.

Learn more about the role of laboratory medicine professionals and pathologists, including a review of testing techniques and applications as well as lab-specific regulations and their impact on biomarker testing.

Hear clinical updates in the diagnosis, treatment, and care of patients with hepatobiliary and pancreatic cancers. Hosted by the Hawaii Society of Clinical Oncology—a Chapter Member of the Association of Community Cancer Centers.

Explore clinical updates in adjuvant and neoadjuvant therapies for breast cancer of all subtypes, and new treatment strategies for breast cancer brain metastases with an emphasis on HER2+ breast cancer. Hosted by the Hawaii Society of Clinical Oncology—a Chapter Member of the Association of Community Cancer Centers.

Hear the latest updates on novel therapies for indolent non-Hodgkin lymphoma, treatment sequencing for aggressive non-Hodgkin lymphoma, and treatment options for chronic lymphocytic leukemia. Hosted by the Hawaii Society of Clinical Oncology—a Chapter Member of the Association of Community Cancer Centers.

Discover the use of biomarkers to guide treatment decisions in localized bladder cancer, and first line and systemic therapy for the treatment of metastatic urothelial cancer. Hosted by the Hawaii Society of Clinical Oncology—a Chapter Member of the Association of Community Cancer Centers.

Hear finding and experiences of ACCC member programs who successfully orchestrated a quality improvement project to expand BRCA testing for eligible patients with breast cancer.

The David King Community Clinical Scientist Award recognizes individuals who have demonstrated leadership in the development, participation, and evaluation of clinical studies and/or are active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients.

The Clinical Research Award recognizes individuals whose research has significantly and positively impacted the oncology patient, family, and/or community.